IDH2 and breast cancer: Moreover, expression of an acetylation mimetic IDH2 mutant (IDH2K413Q) in the breast cancer cell line MCF7 was associated with increased cellular ROS and glycolysis, decreased mitochondrial respiration capacity and adenosine triphosphate (ATP) production, promotion of cell transformation and tumorigenesis in nude mice [83].